-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2025-surv-rep-update-tables-e1-4.xlsx
January 01, 2025 - mg/day for 8 weeks 400 mg/day NA NA NA NA 8 Short None Low
38033459 Pramhas, 2023 RCT No No Austria Musculoskeletal … and 2 oxycodone tablets NA NA 6 Short Government Moderate
34510141 Vela, 2021 RCT No No Denmark Musculoskeletal … NR NA NA NR NR NR NR NR NR Daily analgesic intake; pain free days/month
Pramhas, 2023 None Moderate Musculoskeletal … Vela, 2021 None Moderate Musculoskeletal Hand osteoarthritis and psoriatic arthritis Synthetic CBD 10 … AEs were not reported by proportion of patients
Vela, 2021 None Moderate Musculoskeletal Hand osteoarthritis
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-227-noninvasive-nonpharm-chronic-pain-comments.pdf
April 16, 2020 - Our literature
search included terms for "musculoskeletal
manipulation" which is an umbrella term/MeSH … effects of a novel psychological attribution and
emotional awareness and expression therapy for chronic
musculoskeletal
-
effectivehealthcare.ahrq.gov/health-topics/herniated-disk
-
effectivehealthcare.ahrq.gov/products/fibromyalgia/research-protocol
-
effectivehealthcare.ahrq.gov/health-topics/osteoarthritis
-
effectivehealthcare.ahrq.gov/health-topics/sports-injuries
-
effectivehealthcare.ahrq.gov/health-topics/spinal-stenosis
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/topic-brief2-opioid-withdrawal.pdf
April 01, 2021 - www.clinicaltrials.gov/
A-2
2 Chronic Pain/
3 exp arthralgia/ or exp back pain/ or exp headache/ or exp musculoskeletal … persistent or intractable or refractory) adj3 pain).ti,ab,kw.
8 (((back or spine or spinal or leg or musculoskeletal
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/topic-brief2-opioid-withdrawal.pdf
April 01, 2021 - www.clinicaltrials.gov/
A-2
2 Chronic Pain/
3 exp arthralgia/ or exp back pain/ or exp headache/ or exp musculoskeletal … persistent or intractable or refractory) adj3 pain).ti,ab,kw.
8 (((back or spine or spinal or leg or musculoskeletal
-
effectivehealthcare.ahrq.gov/health-topics/fibromyalgia
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-pain-opioid-treatment_executive.pdf
September 19, 2014 - does effectiveness vary depending on: (1) the
specific type or cause of pain (e.g., neuropathic,
musculoskeletal … How do harms vary depending on: (1) the specific type
or cause of pain (e.g., neuropathic, musculoskeletal … does effectiveness vary depending on: (1)
the specific type or cause of pain (e.g., neuropathic,
musculoskeletal … How do harms vary depending on: (1) the
specific type or cause of pain (e.g., neuropathic,
musculoskeletal
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-1-noninvasive-nonpharma_0.xlsx
January 01, 2021 - 3 to 4 spondylolisthesis; fibromyalgia , or systemic/inflammatory disorder, current lower extremity musculoskeletal … vs. 2.93 (0.93), p=0.15 NR NR NR Supported by a grant from the National Institute of Arthritis and Musculoskeletal … 126) vs. 0% (0/124) Supported by grants 1R01AR059105-01 from the National Institute of Arthritis and Musculoskeletal … calculable (NC)
Not reported (NR)
Numerical Pain Scale (NPS)
Numerical Rating Scale (NRS)
Örebro Musculoskeletal
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-2-noninvasive-nonpharma.xlsx
January 01, 2021 - 3 to 4 spondylolisthesis; fibromyalgia , or systemic/inflammatory disorder, current lower extremity musculoskeletal … vs. 2.93 (0.93), p=0.15 NR NR NR Supported by a grant from the National Institute of Arthritis and Musculoskeletal … 126) vs. 0% (0/124) Supported by grants 1R01AR059105-01 from the National Institute of Arthritis and Musculoskeletal … calculable (NC)
Not reported (NR)
Numerical Pain Scale (NPS)
Numerical Rating Scale (NRS)
Örebro Musculoskeletal
-
effectivehealthcare.ahrq.gov/health-topics/joint-disorders
-
effectivehealthcare.ahrq.gov/health-topics/scleroderma
-
effectivehealthcare.ahrq.gov/health-topics/marfan-syndrome
-
effectivehealthcare.ahrq.gov/health-topics/scoliosis
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-executive-summary-2023-update.pdf
January 01, 2023 - 57% 57%
% Non-White
(Study Count)
54% (1); NR (5) NR NR NR NR
Primary Pain
Type(s)
Mixed
musculoskeletal
-
effectivehealthcare.ahrq.gov/health-topics/vitiligo
-
effectivehealthcare.ahrq.gov/health-topics/bone-diseases